We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+10.39%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$4B
AUM Growth
+$132M
Cap. Flow
-$179M
Cap. Flow %
-4.48%
Top 10 Hldgs %
18.79%
Holding
1,371
New
119
Increased
418
Reduced
646
Closed
96

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$6.17M
2
CARR icon
Carrier Global
CARR
+$5.55M
3
LOW icon
Lowe's Companies
LOW
+$5.28M
4
ZTS icon
Zoetis
ZTS
+$5.18M
5
PENN icon
PENN Entertainment
PENN
+$5.17M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$22.3M
2
AAPL icon
Apple
AAPL
+$19M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$14.4M
4
META icon
Meta Platforms (Facebook)
META
+$11.1M
5
MSFT icon
Microsoft
MSFT
+$11M

Sector Composition

Rank Sector Weight
1 Technology 18.68%
2 Healthcare 12.39%
3 Consumer Discretionary 10.38%
4 Financials 10.05%
5 Industrials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACCO icon
1226
Acco Brands
ACCO
$390M
$107K ﹤0.01%
18,430
+61
+0.3% +$399
DCF
1227
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$106K ﹤0.01%
13,195
+3,100
+31% +$24.9K
NBSE
1228
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$105K ﹤0.01%
+690
New +$113K
GEG icon
1229
Great Elm Group
GEG
$68.4M
$101K ﹤0.01%
42,865
TXMD icon
1230
TherapeuticsMD
TXMD
$23.5M
$97K ﹤0.01%
1,227
+248
+25% +$19.8K
BMY.RT
1231
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$97K ﹤0.01%
42,794
-4,157
-9% -$11.9K
RLJ icon
1232
RLJ Lodging Trust
RLJ
$1.87B
$94K ﹤0.01%
10,860
HGLB
1233
Highland Global Allocation Fund
HGLB
$172M
$93K ﹤0.01%
15,000
ICMB icon
1234
Investcorp Credit Management BDC
ICMB
$11.2M
$93K ﹤0.01%
25,715
ADT icon
1235
ADT
ADT
$5.51B
$92K ﹤0.01%
+11,200
New +$109K
SAN icon
1236
Banco Santander
SAN
$202B
$85K ﹤0.01%
47,792
-1,357
-3% -$2.92K
SHO icon
1237
Sunstone Hotel Investors
SHO
$2.18B
$83K ﹤0.01%
10,404
JTA
1238
DELISTED
Nuveen Tax-Advantaged Total Return Strategy Fund
JTA
$80K ﹤0.01%
10,000
-4,390
-31% -$36.5K
CBUS icon
1239
Cibus
CBUS
$147M
$78K ﹤0.01%
284
AMRS
1240
DELISTED
Amyris Inc.
AMRS
$78K ﹤0.01%
26,711
+2,611
+11% +$9.57K
JMM icon
1241
Nuveen Multi-Market Income Fund
JMM
$54.9M
$74K ﹤0.01%
10,650
TCRT icon
1242
Alaunos Therapeutics
TCRT
$4.59M
$73K ﹤0.01%
193
ENLC
1243
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$72K ﹤0.01%
30,757
-2,300
-7% -$6.08K
SLE icon
1244
Super League Enterprise
SLE
$4.42M
$70K ﹤0.01%
+4
New +$85.8K
PAA icon
1245
Plains All American Pipeline
PAA
$17.5B
$69K ﹤0.01%
11,543
-5,125
-31% -$38.2K
BTG icon
1246
B2Gold
BTG
$5.13B
$66K ﹤0.01%
+10,200
New +$66.3K
CMCM
1247
Cheetah Mobile
CMCM
$88.5M
$64K ﹤0.01%
6,204
OXY.WS icon
1248
Occidental Petroleum Corp Warrants
OXY.WS
$32B
$62K ﹤0.01%
+21,001
New +$67.1K
FEI
1249
DELISTED
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
$62K ﹤0.01%
13,339
CLVS
1250
DELISTED
Clovis Oncology, Inc.
CLVS
$62K ﹤0.01%
10,717
-3,583
-25% -$21.4K

Similar funds

Oppenheimer & Co's Q3 2020 Portfolio in Review

As of Q3 2020, Oppenheimer & Co held 1,371 positions worth $4B, up 3.4% from $3.87B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oppenheimer & Co withdrew a net $179M in Q3 2020, closing 96 positions and reducing 646 holdings. Its most notable exit was Chegg, an estimated $5.41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Oppenheimer & Co opened a new position in PENN Entertainment worth $7.66M.

  • Oppenheimer & Co's largest Q3 2020 buy was PENN Entertainment: 105,394 shares worth $7.66M.
  • Oppenheimer & Co added most to Illumina in Q3 2020, an estimated $6.17M increase.
  • Oppenheimer & Co's biggest Q3 2020 reduction was Amazon, cutting an estimated $22.3M.
  • Oppenheimer & Co fully exited Chegg in Q3 2020, selling an estimated $5.41M.
  • Oppenheimer & Co's ten largest holdings make up 19% of its $4B portfolio in Q3 2020.
  • Oppenheimer & Co opened 119 new positions and closed 96 in Q3 2020.
  • Oppenheimer & Co's portfolio value rose 3.4% quarter-over-quarter to $4B.

Based on Oppenheimer & Co's 13F filing for Q3 2020, filed 13 Nov 2020.